1. Home
  2. ADUS vs CGON Comparison

ADUS vs CGON Comparison

Compare ADUS & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADUS
  • CGON
  • Stock Information
  • Founded
  • ADUS 1979
  • CGON 2010
  • Country
  • ADUS United States
  • CGON United States
  • Employees
  • ADUS N/A
  • CGON N/A
  • Industry
  • ADUS Medical/Nursing Services
  • CGON
  • Sector
  • ADUS Health Care
  • CGON
  • Exchange
  • ADUS Nasdaq
  • CGON NYSE
  • Market Cap
  • ADUS 2.2B
  • CGON 2.3B
  • IPO Year
  • ADUS 2009
  • CGON 2024
  • Fundamental
  • Price
  • ADUS $135.92
  • CGON $30.00
  • Analyst Decision
  • ADUS Buy
  • CGON Strong Buy
  • Analyst Count
  • ADUS 10
  • CGON 10
  • Target Price
  • ADUS $133.67
  • CGON $65.11
  • AVG Volume (30 Days)
  • ADUS 133.5K
  • CGON 809.2K
  • Earning Date
  • ADUS 02-24-2025
  • CGON 02-02-2025
  • Dividend Yield
  • ADUS N/A
  • CGON N/A
  • EPS Growth
  • ADUS 23.71
  • CGON N/A
  • EPS
  • ADUS 4.37
  • CGON N/A
  • Revenue
  • ADUS $1,133,806,000.00
  • CGON $684,000.00
  • Revenue This Year
  • ADUS $10.52
  • CGON $210.00
  • Revenue Next Year
  • ADUS $24.53
  • CGON N/A
  • P/E Ratio
  • ADUS $30.67
  • CGON N/A
  • Revenue Growth
  • ADUS 10.15
  • CGON 258.12
  • 52 Week Low
  • ADUS $85.94
  • CGON $25.77
  • 52 Week High
  • ADUS $136.68
  • CGON $50.23
  • Technical
  • Relative Strength Index (RSI)
  • ADUS 70.58
  • CGON 49.32
  • Support Level
  • ADUS $124.16
  • CGON $28.67
  • Resistance Level
  • ADUS $127.00
  • CGON $29.69
  • Average True Range (ATR)
  • ADUS 2.25
  • CGON 1.38
  • MACD
  • ADUS 0.92
  • CGON 0.21
  • Stochastic Oscillator
  • ADUS 94.10
  • CGON 52.15

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: